GDUFA Research Outcomes
Topical Products
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to locally acting generic products administered via the topical route, including topical dermatological products.
- 
                        Overview of Breakout Session on Topical Drug Products: Workshop on Complex Generic Drug Products (CGDPs)
                        Raney, Sam 
- 
                        When Do Formulation Differences in Topical Dosage Forms Impact Their Function: Emerging Insights and Implications for Bioequivalence Approaches
                        Raney, Sam 
- 
                        Advances in Topical Bioequivalence Assessments: Characterization-Based Approaches
                        Raney, Sam 
- 
                        A Generic Drugs Perspective on the Use of In Vitro Assesment Methods
                        Raney, Sam 
- 
                        Research Activities, Scientific Advances, & Modernization of Bioequivalence Standards for Generic Topical and Transdermal Products
                        Raney, Sam 
- 
                        A Generic Perspective On The Use Of In Vitro Assessment Methods
                        Raney, Sam 
- 
                        FDA Initiatives to Stimulate Innovation and Imporve Patient Access to Generic Topical & Transdermal Products Part l
                        Raney, Sam 
- 
                        Overview of Current Science Based Regulatory Standards
                        Raney, Sam 
- 
                        Questions about the Proposed Topical Classification System (TCS), and What To Do With It.
                        Raney, Sam 
- 
                        FDA Regulatory Initiatives Related to Generic Dermatological and Transdermal Drug Products
                        Raney, Sam